Screener
Integra LifeSciences IART Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Integra LifeSciences’s reported figures.
Based on trailing twelve months.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
FAQ
- What is Integra LifeSciences's return on equity?
- Integra LifeSciences (IART) reported return on equity of -0.7% in Q2 2026.
- What is the long-term trend for Integra LifeSciences's return on equity?
- Over 4 years (2020 to 2025), Integra LifeSciences's return on equity has grown at a 44.6% compound annual growth rate (CAGR), from 9.1% to -39.9%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Integra LifeSciences's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude